find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
23
Clinical Trials
Leukemia
N/A
Enrolling
nct/study# N/A / QUIZ-REAL-WORLD-PROJECT
Real-world comparative effectiveness and safety of FLT3 inhibitors combined with induction chemotherapy in acute myeloid leukemia
Learn More
Leukemia
N/A
Enrolling
nct/study# NCT06456463 / STML-401-0423
STML-401-0423 A Phase II Multicenter Open-Label Trial of Tagraxofusp (TAG) in Combination with Venetoclax and Azacitadine (VEN/AZA) in Adults with Previously Untreated CD123+ Acute Myeloid Leukemia (AML) who are Ineligible for Intensive Chemotherapy
Learn More
Leukemia
N/A
Enrolling
nct/study# N/A / VENETOCLAX-AML
Effect of Adding Venetoclax to Intensive Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
Learn More
Leukemia
N/A
Enrolling
nct/study# N/A / VENETOCLAX-VEN-HMA
Genotypic signatures of response to Venetoclax and Hypomethylating agent in treatment naive Acute Myeloid Leukemia and Myelodysplastic Syndrome
Learn More
Leukemia
N/A
Enrolling
nct/study# N/A / VYXEOS-VS-VEN-HMA
CPX-351 vs. Venetoclax +Ven-HMA Retrospective Chart Review
Learn More
Leukemia
Phase I
Enrolling
nct/study# NCT06419634 / CA235-0001
Phase I Multicenter, Open-Label, First-in-Human Study Of ORM 6151 in Subjects With Relapsed Or Refractory Acute Myeloid Leukemia Or Myelodysplastic Syndrome-Increased Blasts 2
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.